Argenx (ARGX) announced that Karen Massey, current COO, will transition to CEO and executive director and Tim Van Hauwermeiren, current CEO, will transition to non-executive director and chairman of the board of directors. Tim will succeed Peter Verhaeghe, who is retiring from the board of directors after dedicated service to the company since 2008. These changes are subject to shareholder approval at the annual general meeting on May 6.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARGX:
- Argenx price target raised to $1,006 from $942 at BofA
- Argenx price target raised to $1,160 from $1,085 at Guggenheim
- Argenx downgraded to Neutral from Outperform at Baird
- argenx: Strong Growth and Pipeline Potential Already Priced In, Warranting a Neutral/Hold Rating
- Argenx Moves Ahead With Its Phase 2 Study on ARGX-119 for Pediatric SMA